ARK Investment Management - VASCULAR BIOGENICS LTD ownership

VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 28 filers reported holding VASCULAR BIOGENICS LTD in Q1 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.

Quarter-by-quarter ownership
ARK Investment Management ownership history of VASCULAR BIOGENICS LTD
ValueSharesWeighting
Q4 2021$2,621,000
-8.3%
1,330,206
-4.5%
0.01%
+14.3%
Q3 2021$2,857,000
+1551.4%
1,393,460
+1749.2%
0.01%
-22.2%
Q1 2018$173,000
-42.7%
75,354
+77.4%
0.01%
-62.5%
Q4 2017$302,00042,4840.02%
Other shareholders
VASCULAR BIOGENICS LTD shareholders Q1 2022
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 92,000$189,0000.26%
Ikarian Capital, LLC 790,838$1,622,0000.11%
PVG ASSET MANAGEMENT CORP 12,365$25,348,0000.08%
Phoenix Holdings Ltd. 1,020,000$2,091,0000.04%
DAFNA Capital Management LLC 55,000$113,0000.03%
ARK Investment Management 1,393,460$2,857,0000.01%
BOOTHBAY FUND MANAGEMENT, LLC 79,716$163,0000.01%
Total Clarity Wealth Management, Inc. 4,000$8,0000.00%
Virtu Financial LLC 15,298$31,0000.00%
Altshuler Shaham Ltd 209,000$431,0000.00%
View complete list of VASCULAR BIOGENICS LTD shareholders